Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading update

6 Apr 2022 07:00

RNS Number : 3775H
FD Technologies PLC
06 April 2022
 

 

 

6 April 2022

FD Technologies plc

("FD Technologies" or the "Group")

 

Trading update

 

Delivering on accelerated growth strategy

FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) today provides a trading update for the financial year ending 28 February 2022 in advance of full year results expected to be announced on 10 May 2022.

The Group expects to achieve its revenue and adjusted EBITDA guidance for the year. Delivery of the accelerated growth strategy announced in May 2021 remains on track, enabling KX to achieve its target of 25% growth in exit Annual Recurring Revenue, driven by increasing take-up of the KX Insights platform. Combined with the recent announcement of our strategic partnership with Microsoft means we have entered the new financial year in a position to build on this momentum.

Seamus Keating, CEO of FD Technologies, commented: "I am pleased with our financial performance and the execution of our accelerated growth strategy in what was a year of transformation for the Group. I'm excited by the opportunities across our business as we win new customers and continue to develop our offering to drive value, performance and returns."

Enquiries

For further information please contact:

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0) 28 3025 2242

www.fdtechnologies.com

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Virginia Bull

+44 (0) 20 7597 5970

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 1 667 0420

J.P. Morgan Cazenove (Broker)

James A. Kelly

Mose Adigun

+44 (0) 20 7742 4000

 

FTI Consulting (PR Adviser)

+44 (0) 20 3727 1000

Matt Dixon

Dwight Burden

Elena Kalinskaya

 

About FD Technologies

FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, the leading technology for real-time continuous intelligence; First Derivative, which provides technology-led services in capital markets; and MRP, the only enterprise-class, predictive Accounts Based Marketing solution. FD Technologies operates from 15 offices across Europe, North America and Asia Pacific, and employs more than 3,000 people worldwide.

For further information, please visit www.fdtechnologies.com and www.kx.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSEFIIEESEIL
Date   Source Headline
2nd Jul 20187:02 amRNSFD to buy out minority Kx Systems shareholders
29th Jun 201811:32 amRNSTotal Voting Rights
27th Jun 20181:03 pmRNSAGM Statement
15th Jun 20186:01 pmRNSHolding(s) in Company
8th Jun 20188:00 amRNSEnterprise Securities Market Notice
7th Jun 201810:43 amRNSHolding(s) in Company
5th Jun 20184:51 pmRNSNotice of AGM
1st Jun 20184:14 pmRNSIssue of Equity
22nd May 20187:00 amRNSPreliminary results for the year ended 28 Feb 2018
17th May 20187:02 amRNSKx provides rapid access to unstructured data
25th Apr 20187:00 amRNSTrading update and Notice of Results
3rd Apr 201810:00 amRNSTotal Voting Rights
23rd Mar 20187:00 amRNSEnterprise Securities Market Notice
19th Mar 201810:09 amRNSIssue of Equity
28th Feb 20189:01 amRNSTotal Voting Rights
20th Feb 20187:00 amRNSContract Win in Gaming
7th Feb 20187:00 amRNSEnterprise Securities Market Notice
1st Feb 20185:23 pmRNSIssue of Equity
31st Jan 20183:40 pmRNSTotal Voting Rights
15th Jan 20187:00 amRNSAppointment of Non-Executive Director
4th Jan 20187:00 amRNSEnterprise Securities Market Notice
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20177:00 amRNSIssue of Equity
19th Dec 20174:06 pmRNSDirector/PDMR Shareholding
18th Dec 20174:07 pmRNSIssue of Equity
14th Dec 20177:00 amRNSEnterprise Securities Market Notice
11th Dec 20177:00 amRNSTelco Acquisition
7th Dec 20177:00 amRNSEnterprise Securities Market Notice
1st Dec 20174:31 pmRNSIssue of Equity
30th Nov 20178:36 amRNSTotal Voting Rights
22nd Nov 201710:35 amRNSHolding(s) in Company
21st Nov 20174:54 pmRNSHolding(s) in Company
16th Nov 20177:00 amRNSEnterprise Securities Market Notice
10th Nov 201712:32 pmRNSIssue of Equity and Dividend Timetable Amendment
7th Nov 20177:00 amRNSHalf Yearly Report
6th Nov 20177:00 amRNSKx selected by Red Bull Racing
13th Oct 20177:00 amRNSNotice of Results
2nd Oct 20179:09 amRNSTotal Voting Rights
19th Sep 20177:00 amRNSMajor Machine Learning Investment in Kx Technology
5th Sep 20177:00 amRNSEnterprise Securities Market Notice
30th Aug 20173:04 pmRNSIssue of Equity
23rd Aug 201712:20 pmRNSHolding(s) in Company
31st Jul 201711:58 amRNSTotal Voting Rights
28th Jul 20177:00 amRNSEnterprise Securities Market Notice
25th Jul 20177:00 amRNSHolding(s) in Company
24th Jul 20174:26 pmRNSIssue of Equity from exercise of Share Options
7th Jul 20177:00 amRNSEnterprise Securities Market Notice
3rd Jul 20174:23 pmRNSIssue of Equity from exercise of Share Options
30th Jun 201710:48 amRNSTotal Voting Rights
23rd Jun 20171:50 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.